Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease.

Hebert PR, Hennekens CH.

Arch Intern Med. 2000 Nov 13;160(20):3123-7.

PMID:
11074741
[PubMed - indexed for MEDLINE]
2.

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL.

JAMA. 2006 Jan 18;295(3):306-13. Erratum in: JAMA. 2006 May 3;295(17):2002.

PMID:
16418466
[PubMed - indexed for MEDLINE]
3.

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Berger JS, Krantz MJ, Kittelson JM, Hiatt WR.

JAMA. 2009 May 13;301(18):1909-19. doi: 10.1001/jama.2009.623.

PMID:
19436018
[PubMed - indexed for MEDLINE]
4.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

PMID:
12512736
[PubMed - indexed for MEDLINE]
Free Article
5.

An update on aspirin in the primary prevention of cardiovascular disease.

Eidelman RS, Hebert PR, Weisman SM, Hennekens CH.

Arch Intern Med. 2003 Sep 22;163(17):2006-10.

PMID:
14504112
[PubMed - indexed for MEDLINE]
6.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

PMID:
15753114
[PubMed - indexed for MEDLINE]
Free Article
7.

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):56-65.

PMID:
15998891
[PubMed - indexed for MEDLINE]
8.

Prevention of cardiovascular disease: risks and benefits of aspirin.

Buring JE, Hennekens CH.

J Gen Intern Med. 1990 Sep-Oct;5(5 Suppl):S54-7. Review.

PMID:
2231066
[PubMed - indexed for MEDLINE]
9.

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

Ridker PM, Manson JE, Gaziano JM, Buring JE, Hennekens CH.

Ann Intern Med. 1991 May 15;114(10):835-9.

PMID:
2014943
[PubMed - indexed for MEDLINE]
10.

A prospective study of aspirin use and primary prevention of cardiovascular disease in women.

Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH.

JAMA. 1991 Jul 24-31;266(4):521-7.

PMID:
2061978
[PubMed - indexed for MEDLINE]
11.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
[PubMed - indexed for MEDLINE]
12.

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R.

Arch Intern Med. 2004 Jan 12;164(1):40-4.

PMID:
14718320
[PubMed - indexed for MEDLINE]
13.

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.

Hayden M, Pignone M, Phillips C, Mulrow C.

Ann Intern Med. 2002 Jan 15;136(2):161-72.

PMID:
11790072
[PubMed - indexed for MEDLINE]
14.

Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.

Hart RG, Halperin JL, McBride R, Benavente O, Man-Son-Hing M, Kronmal RA.

Arch Neurol. 2000 Mar;57(3):326-32.

PMID:
10714657
[PubMed - indexed for MEDLINE]
15.

Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.

Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, Sivenius J, Yatsu F, Dewey ME; Dipyridamole in Stroke Collaboration (DISC).

Stroke. 2005 Jan;36(1):162-8. Epub 2004 Nov 29. Review.

PMID:
15569877
[PubMed - indexed for MEDLINE]
Free Article
16.

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative Group.

Diabetes Care. 2003 Dec;26(12):3264-72.

PMID:
14633812
[PubMed - indexed for MEDLINE]
17.

Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.

Wolff T, Miller T, Ko S.

Ann Intern Med. 2009 Mar 17;150(6):405-10. Review.

PMID:
19293073
[PubMed - indexed for MEDLINE]
18.

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.

Berger JS, Brown DL, Becker RC.

Am J Med. 2008 Jan;121(1):43-9. doi: 10.1016/j.amjmed.2007.10.002. Review.

PMID:
18187072
[PubMed - indexed for MEDLINE]
19.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

PMID:
15461876
[PubMed - indexed for MEDLINE]
Free Article
20.

Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study.

Cook NR, Hebert PR, Manson JE, Buring JE, Hennekens CH.

Arch Intern Med. 2000 Apr 10;160(7):921-8.

PMID:
10761956
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk